Bates S, Peters G
Imperial Cancer Research Fund Laboratories, London, UK.
Semin Cancer Biol. 1995 Apr;6(2):73-82. doi: 10.1006/scbi.1995.0010.
Deregulated expression of cyclin D1 occurs in several types of human cancer. Since it often results from a specific chromosomal abnormality, this over-expression is likely to be significant in the development of the disease. Cyclin D1 is also implicated in virally induced tumors in mice and transgenic models based on ectopic expression if cyclin D1 recapitulate features of the naturally occurring tumors. By these criteria, as well as its effects in transfected rodent cells, cyclin D1 has the hallmarks of a cellular proto-oncogene. Although the normal role of cyclin D1 is not well understood, its oncogenic properties appear to involve functional interactions with cyclin-dependent kinases, the retinoblastoma gene product and the MTS1/p16 tumor suppressor gene.
细胞周期蛋白D1的表达失调在多种人类癌症中都有发生。由于它常常源于特定的染色体异常,这种过表达在疾病发展过程中可能具有重要意义。在小鼠的病毒诱导肿瘤以及基于细胞周期蛋白D1异位表达的转基因模型中,如果异位表达的细胞周期蛋白D1重现了自然发生肿瘤的特征,那么细胞周期蛋白D1也与这些肿瘤有关。根据这些标准以及它在转染的啮齿动物细胞中的作用,细胞周期蛋白D1具有细胞原癌基因的特征。尽管细胞周期蛋白D1的正常作用尚未完全明确,但其致癌特性似乎涉及与细胞周期蛋白依赖性激酶、视网膜母细胞瘤基因产物以及MTS1/p16肿瘤抑制基因的功能相互作用。